126 related articles for article (PubMed ID: 22778866)
1. ACS chemical neuroscience molecule spotlight on Qnexa.
Mercer SL
ACS Chem Neurosci; 2011 Apr; 2(4):183-4. PubMed ID: 22778866
[TBL] [Abstract][Full Text] [Related]
2. Formulary management of 2 new agents: lorcaserin and phentermine/topiramate for weight loss.
Kelly EM; Tungol AA; Wesolowicz LA
J Manag Care Pharm; 2013 Oct; 19(8):642-54. PubMed ID: 24074010
[TBL] [Abstract][Full Text] [Related]
3. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.
Garvey WT; Ryan DH; Look M; Gadde KM; Allison DB; Peterson CA; Schwiers M; Day WW; Bowden CH
Am J Clin Nutr; 2012 Feb; 95(2):297-308. PubMed ID: 22158731
[TBL] [Abstract][Full Text] [Related]
4. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP).
Allison DB; Gadde KM; Garvey WT; Peterson CA; Schwiers ML; Najarian T; Tam PY; Troupin B; Day WW
Obesity (Silver Spring); 2012 Feb; 20(2):330-42. PubMed ID: 22051941
[TBL] [Abstract][Full Text] [Related]
5. Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa.
Dalai SS; Adler S; Najarian T; Safer DL
Contemp Clin Trials; 2018 Jan; 64():173-178. PubMed ID: 29038069
[TBL] [Abstract][Full Text] [Related]
6. Phentermine and topiramate for the management of obesity: a review.
Cosentino G; Conrad AO; Uwaifo GI
Drug Des Devel Ther; 2013; 7():267-78. PubMed ID: 23630412
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness Analysis of Qsymia for Weight Loss.
Finkelstein EA; Kruger E; Karnawat S
Pharmacoeconomics; 2015 Jul; 33(7):699-706. PubMed ID: 24986038
[TBL] [Abstract][Full Text] [Related]
8. Recent advancements in drug treatment of obesity.
Carter R; Mouralidarane A; Ray S; Soeda J; Oben J
Clin Med (Lond); 2012 Oct; 12(5):456-60. PubMed ID: 23101148
[TBL] [Abstract][Full Text] [Related]
9. SMART use of medications for the treatment of adolescent severe obesity: A sequential multiple assignment randomized trial protocol.
Fox CK; Vock DM; Sherwood NE; Gross AC; Ryder JR; Bensignor MO; Bomberg EM; Sunni M; Bramante CT; Jacobs N; Raatz SJ; Kelly AS
Contemp Clin Trials; 2024 Mar; 138():107444. PubMed ID: 38219798
[TBL] [Abstract][Full Text] [Related]
10. Anorectic interaction and safety of 5-hydroxytryptophan/carbidopa plus phentermine or diethylpropion in rat.
Limón-Bernal E; Roa-Coria JE; Zúñiga-Romero Á; Huerta-Cruz JC; Ruíz-Velasco IRC; Flores-Murrieta FJ; Lara-Padilla E; Reyes-García JG; Rocha-González HI
Behav Pharmacol; 2021 Aug; 32(5):368-381. PubMed ID: 33660661
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for Patients with Obesity.
Gadde KM; Apolzan JW; Berthoud HR
Clin Chem; 2018 Jan; 64(1):118-129. PubMed ID: 29054924
[TBL] [Abstract][Full Text] [Related]
12. Combination Therapy: A New Tool for the Management of Obesity.
Prabhakar PK
Endocr Metab Immune Disord Drug Targets; 2024; 24(4):402-417. PubMed ID: 37641995
[TBL] [Abstract][Full Text] [Related]
13. Current and future drug targets in weight management.
Witkamp RF
Pharm Res; 2011 Aug; 28(8):1792-818. PubMed ID: 21181547
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for childhood obesity: present and future prospects.
Sherafat-Kazemzadeh R; Yanovski SZ; Yanovski JA
Int J Obes (Lond); 2013 Jan; 37(1):1-15. PubMed ID: 22929210
[TBL] [Abstract][Full Text] [Related]
15. Effect of phentermine on weight reduction in a pediatric weight management clinic.
Ryder JR; Kaizer A; Rudser KD; Gross A; Kelly AS; Fox CK
Int J Obes (Lond); 2017 Jan; 41(1):90-93. PubMed ID: 27773937
[TBL] [Abstract][Full Text] [Related]
16. A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity.
Kim A; Nguyen J; Babaei M; Kim A; Geller DH; Vidmar AP
Adolesc Health Med Ther; 2023; 14():125-140. PubMed ID: 37641650
[TBL] [Abstract][Full Text] [Related]
17. New central targets for the treatment of obesity.
Sargent BJ; Moore NA
Br J Clin Pharmacol; 2009 Dec; 68(6):852-60. PubMed ID: 20002079
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Phentermine and its Derivatives.
Upadhyaya K; Shukla S; Meena BP; Dwivedi J
Curr Org Synth; 2024; 21(5):583-594. PubMed ID: 37259208
[TBL] [Abstract][Full Text] [Related]
19. Duration of therapy of cost-subsidised phentermine and topiramate in patients with obesity: A retrospective medical records audit of an Australian single site.
Houssarini JA; Franklin J; Markovic T; Hocking SL
Obes Res Clin Pract; 2024; 18(1):73-75. PubMed ID: 38365507
[No Abstract] [Full Text] [Related]
20. Current and future pharmacotherapies for obesity in children and adolescents.
Kelly AS
Nat Rev Endocrinol; 2023 Sep; 19(9):534-541. PubMed ID: 37337008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
